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Highlights 
 Qualitative & quantitative demonstration of bead-to-bead transfer for hMSC microcarrier 
culture 
 The phenomenon is used to significantly improve yield and culture performance  
 Reproducible results across 3 different hBM-MSC donors in FBS, HPL and serum-free 
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Human mesenchymal stem cells (hMSCs) are a key candidate for advanced cell therapies with 
numerous clinical trials investigating their potential to treat acute and chronic indications. However, 
important translational and manufacturing challenges need to be addressed to improve our 
capability for scalable production of fully functional cells. In this study, we have demonstrated, both 
qualitatively and quantitatively, the ability of bone marrow-derived hMSCs to migrate from one 
microcarrier to another, and, to populate fresh microcarriers when added into suspension culture. 
Additionally, we have shown that compared to inoculating a culture with cells in free suspension, 
inoculating 10% of near-confluent microcarriers from an initial seed microcarrier culture resulted in 
an increase in the cell growth rate and overall cell yield and a significant reduction in the lag phase. 
These findings were consistent across cells from three different BM-hMSC donors and across 
different culture medium conditions, foetal bovine serum-supplemented medium, human platelet 
lysate-supplemented medium and serum-free medium. This new cells-on-beads inoculation 
method is an effective means of process intensification with the potential to decrease 
manufacturing times and potentially costs of hMSC-based therapies.  
Keywords: human mesenchymal stem cells; cell therapy bioprocessing; microcarriers; bioreactor; 
regenerative medicine; bead to bead transfer; process intensification  
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1. Introduction 
Advanced therapies, including cell and gene-based therapies, will form the next generation of 
therapeutics which have the potential to address unmet clinical need, treat chronic conditions and 
offer potential cures rather than simply alleviating patient symptoms (Barry and Murphy 2013). 
Adherent, or anchorage-dependent cells, are likely to be promising candidates for both autologous 
(patient-specific) and allogeneic (universal donor) cell-based therapies; such cells include human 
adult mesenchymal stem cells (hMSCs), human embryonic stem cells (hESCs) and human induced 
pluripotent stem cells (hiPSCs). However, the growth of adherent cells presents additional 
challenges in comparison to suspension cell platforms, and has therefore been the subject of 
considerable research activity (Rafiq 2016). Initially in the 1980s and 1990s, significant effort was 
directed at the production of adherent Chinese Hamster Ovary (CHO) cells for protein/vaccine 
production, and more recently, for the production of adherent stem cells for cell therapy 
applications. Established techniques for the growth of these cells involve monolayer culture, 
predominantly in tissue-culture flasks or roller bottles. However, as was recognised for adherent 
CHO cells in the 1980s, alternative manufacturing processes for the production of adherent cells 
are required which are scalable, robust, reproducible and cost-effective. This is achieved through 
the use of microcarriers in stirred-tank bioreactor systems and have been used for multiple cell 
types including CHO (Ohlson et al. 1994), hMSCs (Dos Santos et al. 2011; Rafiq et al. 2013a), 
hESCs (Chen et al. 2010) and hiPSCs (Badenes et al. 2017; Bardy et al. 2013). 
In monolayer culture, cell growth is maintained by keeping the cells in the log phase of the culture 
and is based upon ‘confluency’, the proportion of adherent cells covering the attachment surface. 
When cells reach an appropriate confluency level (usually 80% but can differ based on cell type), 
the cells are removed from the surface and plated into new tissue culture flasks in order to keep 
them in the exponential phase, a process known as passaging. The process of passaging typically 
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requires the use of a proteolytic enzyme such as trypsin, dispase or collagenase (Lindner et al. 
1987) in conjunction with a chelating agent such as EDTA. The exposure of adherent cells to these 
reagents in the absence of serum-containing medium enables the digestion and cleaving of cell 
attachment proteins. However, frequent exposure to such reagents has been demonstrated to have 
adverse effects on mammalian cells including proteome alteration (Huang et al. 2010) and effects 
on cell shape and chromatin structure (Kapiszewska et al. 1991). As such there is concern 
regarding the consecutive passaging of cells, in part due to the long-term deleterious effects of 
dissociation reagents on the cell cytoskeleton (Madeira et al. 2012). Although enzyme-free 
dissociation buffers also exist, some formulations may not be suitable for use with hMSCs. For 
example, a study using a Gibco-brand enzyme-free dissociation buffer to detach hMSCs grown on 
tissue culture plastic found that not only was cell viability following detachment significantly reduced 
compared to trypsin controls (~ 70% compared to > 90%, respectively) but cells also failed to 
reattach to tissue culture plastic (Heng et al. 2009). 
Until now, hMSC microcarrier culture has followed the same approach as monolayer culture with 
respect to harvesting when cells reach confluency, i.e. the use of enzymes to detach cells from the 
surface of the microcarriers, preferably aided by agitation to reduce the time the cells are exposed 
to that environment (Nienow et al. 2014). However, unlike monolayer culture which is limited by the 
surface area available in the tissue culture flask, microcarrier/bioreactor culture has a significant 
advantage with respect to surface area to volume ratio and there is potential for the provision of 
additional microcarriers during a culture process when the cells are nearing confluency in order to 
maintain cell growth in the exponential phase for longer. For example, Hervy and colleagues 
recently maintained hMSCs on microcarriers for over 40 days using this approach (Hervy et al. 
2014). This extended culture time relies on the transfer of cells from one microcarrier/bead to 
another (called here for convenience, bead-to-bead transfer). Bead-to-bead transfer (or cell 
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migration from one microcarrier to another) during suspension culture of adherent cells is believed 
to be a key mechanism for rapid and efficient cell expansion in suspension cultures (de Soure et 
al. 2016). This cell behaviour is of particular interest from a process development and 
manufacturing perspective as the demonstration of bead-to-bead transfer would facilitate the large-
scale manufacture of stem cells via seed bioreactor cultures without the need to expose the cells 
to frequent deleterious proteolytic enzymes. This approach also facilitates process intensification 
by providing additional surface throughout the course of the culture, maintaining the cells in the 
exponential phase of growth for a longer period of time, thereby increasing yield and efficiency 
whilst reducing process costs and time. 
Although investigated and proven for adherent CHO and Vero cells (Ohlson et al. 1994; Wang and 
Ouyang 1999), work demonstrating such a phenomenon for hMSCs has to date focused on single 
hMSC donors (Takahashi et al. 2017), or an immortalised cell line (hMSC-TERT) (Leber et al. 2017) 
or it included complex agitation regimes (Hervy et al. 2014). In this study, we demonstrate, both 
qualitatively and quantitatively, the phenomenon of bead-to-bead transfer for three donor BM-
hMSCs on different microcarriers (Plastic P102-L, Cytodex-3 and Hillex) in different culture medium 
conditions, foetal bovine serum (FBS), human platelet lysate (HPL) and serum-free medium (SFM). 
We also explore the use of a cells-on-beads inoculation procedure, which subsequently utilises 
bead-to-bead transfer (henceforth called ‘cells-on-beads inoculation’), in contrast to the standard 
free suspension inoculation procedure to facilitate process intensification. Several important 
parameters were measured throughout the culture including cell growth kinetics, viability, key 
metabolite consumption and production, immune-phenotype and differentiation potential.  
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2.1 hMSC monolayer expansion 
Human MSCs from three donors were used in this study. All were isolated from bone-marrow 
aspirate and obtained from Lonza (Walkersville, USA) after the donors provided informed consent. 
The university’s local Ethical Committee approved the use of the samples for research. The 
isolation and culture of primary hMSCs is described in Rafiq et al. (2013b); in brief, hMSCs were 
isolated on the basis of plastic adherence and cryopreserved at passage 1 at a density of 2 x 106 
cells/mL in 10 % dimethyl sulphoxide (DMSO) (v/v) (Sigma Aldrich, UK) and 90 % foetal bovine 
serum (FBS; Hyclone, Lot# RUF35869). The cells were cultured according to previously 
determined protocols (Heathman et al. 2016; Heathman et al. 2015a; Heathman et al. 2015b; Rafiq 
et al. 2013a). Briefly, the cells were seeded at 5,000 cells/cm2 and grown on tissue culture plastic 
in DMEM (1 g/L glucose, Lonza, UK) supplemented with 10% (v/v) foetal bovine serum (FBS; 
HyClone) or 10% (v/v) non-heparin requiring (PL-NH) Stemulate™ (Cook Regentec, USA) for the 
human platelet lysate based culture conditions, and 2 mM UltraGlutamine (Lonza, UK).  
Where cells were also cultured under serum-free medium (SFM) conditions, the Prime-XVTM SFM 
hMSC medium was used (Irvine Scientific, USA) in accordance with the manufacturer’s 
instructions. As required, attachment surfaces were pre-coated with recombinant fibronectin (Irvine 
Scientific, USA). For both the SFM and HPL cultures, the BM-hMSCs underwent one adaptation 
passage in medium containing either the Prime-XVTM medium or 10% (v/v) PL-NH Stemulate™.  
2.2 Spinner flask microcarrier culture 
The spinner flask cultures involved the use of 100 mL BellCo spinner flasks (BellCo, USA), with a 
100 mL working volume and a vessel diameter (T) of 60 mm.  The spinner flask vessels were 
siliconized prior to use with Sigmacote (Sigma Aldrich, UK) as described in (Rafiq et al. 2016). The 
spinner flasks were agitated by a magnetic stirrer bar at the just suspended speed (NJS) placed on 
the Bell-EnniumTM Compact 5 position magnetic stirrer platform (BellCo, USA) with air in the 
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headspace for surface aeration giving essentially 100% dO2. The microcarriers were prepared 
according to the manufacturer’s instructions and sterilised by autoclaving at 121ºC and 1 atm for 
15 minutes. Prior to use, the microcarriers were conditioned in growth medium for at least 1 hour 
to facilitate cell attachment. The surface area provided per spinner flask was 500 cm2 and the cells 
were inoculated at a density of 6,000 cells/cm2 as previously described (Rafiq et. al., 2013; 
Heathman et. al., 2015). This inoculation method, referred to later as the ‘control’, is in contrast to 
the ‘cells-on-beads’ inoculation method (discussed later in the results section) which involved 
inoculating 10% of near-confluent microcarriers from an initial seed microcarrier culture. In all 
cases, a 50% medium exchange was performed at 72 h in culture and then every 48 h thereafter.  
2.3 Analytical Techniques 
Cell counts and viability (via acridine orange uptake and DAPI exclusion) were determined using 
the Nucleocounter NC-3000 (Chemometec, UK). Cell viability was also assessed by the Live/Dead 
Viability/Cytotoxicity kit (Calcein AM/ Ethidium Homodimer; Life Sciences, ThermoFisher, UK) 
following the manufacturer’s instructions. Briefly, the cells were first washed with PBS and then 
incubated with the Live/Dead stain containing a final concentration of 2 µM calcein-AM and 4 µM 
ethidium homodimer in the dark at 37ºC and 5% CO2 for 40 minutes. Post incubation, the Live/Dead 
working solution was removed and replaced with PBS. Samples were then visualised on a Nikon 
Ti Eclipse epi-fluorescence microscope (Nikon, UK).  
  
Analysis of glucose and lactate concentrations in the spent medium was performed using a Cedex 
Bio-HT (Roche, Germany). The following parameters were calculated from the data obtained: 
1. Specific Growth Rate 
𝑆𝑝𝑒𝑐𝑖𝑓𝑖𝑐 𝑔𝑟𝑜𝑤𝑡ℎ 𝑟𝑎𝑡𝑒, µ =  
ln(
𝐶𝑥(𝑡)
𝐶𝑥(0)
⁄ )
∆𝑡
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where µ is the net specific growth rate (h-1), Cx(t) and Cx(0) are the cell numbers at the end and 
start of the exponential growth phase, respectively and t is time (h).  
2. Population Doublings 
𝑃𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛 𝐷𝑜𝑢𝑏𝑙𝑖𝑛𝑔𝑠, 𝑃𝑑 =
1
log  (2)
∙ log (
𝐶𝑥(𝑡)
𝐶𝑥(0)
)  
where Pd is the number of population doublings, Cx(t) and Cx(0) are the cell numbers at the end 
and start of the exponential growth phase, respectively. 
3. Specific Metabolite Consumption/Production Rate 
𝑆𝑝𝑒𝑐𝑖𝑓𝑖𝑐 𝑚𝑒𝑡𝑎𝑏𝑜𝑙𝑖𝑡𝑒 𝑓𝑙𝑢𝑥, 𝑞𝑚𝑒𝑡 = (
𝜇
𝐶𝑥(0)
) ∙ (
𝐶𝑚𝑒𝑡(𝑡)−𝐶𝑚𝑒𝑡(0)
𝑒𝜇𝑡−1
)  
where qmet is the net specific metabolite consumption or production rate, µ is the specific growth 
rate (h-1), Cx(0) is the cell number at the end of the exponential growth phase, Cmet(t) and Cmet(0) 
are the metabolite concentrations at the end and start of the exponential growth phase, respectively 
and t is time (h).  
2.4 hMSC Characterisation 
Immunophenotype analysis was performed by multiparameter flow cytometry before and after the 
hMSC expansion process using a previously developed protocol (Chan et al. 2014). In brief, this 
involved the use of flow cytometry where harvested, single cells were suspended in growth medium 
and loaded onto a 96 well plate. The cells were stained with monoclonal antibodies against the 
positive hMSC markers, CD73, CD90 and CD105 and the negative markers, CD34 & HLA-DR (BD 
Biosciences, UK) in addition with the corresponding isotype controls (BD Biosciences, UK). The 
antibodies selected were those recommended by the International Society for Cellular Therapy 
(ISCT) for the characterisation of hMSCs (Dominici et al. 2006).  
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The hMSC differentiation was induced using Prime-XVTM Differentiation SFM (Irvine Scientific, 
USA) as per manufacturer’s instructions. After 21 days, the differentiation media were removed, 
cells rinsed with PBS then fixed with 4% (v/v) PFA at room temperature. Adipocytes were stained 
with 1% (w/v) Oil Red O (Sigma-Aldrich, UK) in isopropanol at room temperature and rinsed with 
distilled water. Osteoblasts were incubated with 2.5% (v/v) silver nitrate (Sigma-Aldrich, UK) under 
ultraviolet light (30 minutes exposure), rinsed with distilled water and stained with fast violet solution 
(Sigma-Aldrich, UK) containing 4% (v/v) napthol AS-MX phosphate alkaline (Sigma-Aldrich, UK) 
for 45 minutes at room temperature in the dark. Chondrocytes were stained with 1% (w/v) Alcian 
blue (Sigma-Aldrich, UK) in 0.1 M hydrochloric acid (Sigma-Aldrich, UK). After 30 minutes 
incubation, cells were rinsed three times with 0.1 M HCl. After staining, differentiated cells were 
visualized under a light microscope (Nikon Eclipse TS-100, UK). 
2.5 Tracking of bead-to-bead cell transfer:  
Bead-to-bead cell transfer was assessed by two methods: 1) by employing visually distinctive 
microcarriers in the same culture system (adding a visually distinctive microcarrier at a later stage 
of the culture) and 2) by fluorescently labelling cells with two different Cell TrackerTM dyes (Life 
Technologies, ThermoFisher Scientific, UK). The use of visually distinctive microcarriers provides 
an effective way of demonstrating bead-to-bead transfer. The cells were originally cultured on the 
Plastic P102-L microcarriers in agitated spinner flask conditions (as described above). After 3 days 
of culture, the visually distinctive microcarriers (either the Hillex or Cytodex-1) were added at the 
same microcarrier concentration during a 50% medium exchange. The culture was continuously 
agitated throughout the addition of the second microcarrier type so that the microcarriers were 
never static. This procedure unequivocally demonstrated the transfer of cells from the Plastic P102-
L microcarrier to the new microcarrier (either Hillex or Cytodex-1).  
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For the fluorescent labelling, Cell TrackerTM Green CMFDA and Cell TrackerTM Red CM-DiI (Life 
Technologies, ThermoFisher Scientific, UK) were employed. Cell TrackerTM Green contains 
chloromethyl derivatives of fluorescein diacetate (CMFDA) and is nonfluorescent until cytosolic 
esterases cleave off the acetates, releasing a brightly fluorescent product. Unlike the Cell TrackerTM 
Green CMFDA, Cell TrackerTM Red CM-DiI is a lipophilic carbocyanine that incorporates a mildly 
thiol-reactive chloro-methyl substituent with affinity for the lipids present inside the cell membrane. 
These reagents pass freely through cell membranes, but once inside the cell, are transformed into 
cell-impermeant reaction products.  
The Cell TrackerTM dyes were used according to the manufacturer’s instructions. Briefly, based on 
the average cell concentration obtained post-harvest, the volume of cell suspension required for 
each experiment to achieve a cell density of 10,000 cells/cm2 was calculated and split in equal 
volumes in two separate centrifuge tubes. Cell pellets were then obtained by centrifuging the cell 
suspensions at 200g for 5 minutes. Each cell pellet was then resuspended in a working solution of 
Cell TrackerTM Red CM-DiI (working concentration of 20 µM) and Cell TrackerTM Green CMFDA 
(working concentration of 20 µM), respectively, and incubated in the dark at 37ºC for 40 minutes. 
After incubation, the Cell TrackerTM working solutions were removed by centrifugation and replaced 
with fresh pre-warmed growth medium. The fluorescently-labelled cells were then seeded at 10,000 
cells/cm2 on the pre-conditioned microcarriers in spinner flasks. Combinations of two different 
microcarriers (Plastic and Cytodex-1) and two different fluorescent dyes were used for this study.  
The labelled cells were allowed to attach and proliferate for 48 h in agitated conditions, in the dark, 
at 37ºC and 5% CO2. After 48 h in culture, the different microcarrier-labelled cell suspensions were 
mixed in a 50:50 proportion and the culture was continued for an additional 2 days. The mixed 
microcarrier-labelled cell suspensions were then imaged on the epi-fluorescence microscope 
mentioned above.  
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2.6 Statistical analysis 
For comparison between the two data sets comparing the mean specific growth rates, statistical 
significance was determined by using the Student’s two-tailed t-test. Significance was determined 
at p < 0.05 (*) or p < 0.01 (**). GraphPad Prism 6 (California, USA) was used for the statistical 
analysis 
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3. Results and Discussion 
The aim of this work was to demonstrate, both quantitatively and qualitatively, the phenomenon of 
bead-to-bead transfer of hMSCs on microcarriers under different culture conditions including cells 
from three BM-hMSC donors and under different culture medium conditions, FBS, HPL and SFM. 
An additional aim was to investigate the potential for process intensification through cells-on-beads 
inoculation, where 10% of near-confluent microcarriers were used to inoculate a fresh microcarrier 
culture. 
Cell-microcarrier contact in bead-to-bead hMSC transfer is very likely to be influenced by a 
combination of factors such as donor cell line, medium composition, attachment substrate (i.e. 
microcarriers) and the process itself. The process employed with respect to the feeding regime, 
surface area provided or agitation intensity was kept constant during this study using a protocol 
that had been thoroughly tested and optimised for the successful expansion of bone-marrow 
derived hMSCs in spinner flasks in different medium conditions (Heathman et al. 2015a; Rafiq et 
al. 2016). To account for donor variability, hMSCs from three donors were employed for this study.  
3.1 Qualitative demonstration of bead-to-bead transfer 
To qualitatively demonstrate hMSC migration from one microcarrier to another, two different 
methods were employed. The first method made use of commercially available microcarriers with 
different visual properties, while the second method consisted of fluorescently-labelling cells, 
followed by tracking their movements in culture.  
Prior work with multiple types of microcarriers in a microcarrier screening study (Rafiq et al. 2016) 
showed that BM-hMSCs would attach and grow on most of the microcarriers albeit with varying 
degrees of success on each. It was also found that certain microcarriers were visually distinctive 
compared to others, for example the Cytodex-1 microcarriers are translucent in comparison to the 
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solid Plastic P102-L microcarriers, and the Hillex microcarriers absorb the phenol red present in 
the medium and therefore turn a dark red colour. To demonstrate the phenomenon of hMSC bead-
to-bead transfer qualitatively, the BM-hMSCs were initially cultured exclusively on Plastic P102-L 
microcarriers for a period of 6 days, after which fresh Hillex microcarriers (Figure 1A-C) or fresh 
Cytodex-1 microcarriers (Figure 1D-F) were aseptically added to the culture without stopping 
agitation of the culture at any point.  
As is indicated by the arrows in the figures, it is evident that BM-MSCs were attached to both the 
Plastic P102-L microcarriers (solid white) and the Hillex (dark red) microcarriers (Figure 1A-C). 
Similarly, cells were  attached to the Plastic P102-L and Cytodex 1 (translucent white) microcarriers 
(Figure 1D-F). The BM-hMSCs were found to be growing on microcarriers of both types as either 
cell-microcarriers aggregates, as well as on individual Plastic P102-L, Hillex and Cytodex-1 
microcarriers (Figure 1A-F). This observation is consistent with both the bridging and cell migration 
methods of bead-to-bead transfer noted by Leber and colleagues in their studies using an 
immortalised hMSC line (Leber et al. 2017). It is worth noting that following the addition of the 
second type of microcarrier to the culture vessel, at no point was the agitation stopped and NJS was 
maintained throughout. These findings therefore provide a qualitative demonstration of bead-to-
bead transfer during a continuing culture, whereby hMSCs have attached and proliferated on ‘fresh’ 
microcarriers days after the addition to the culture. 
To demonstrate that these were indeed viable cells attached to both types of microcarriers (Plastic 
P102-L and Hillex), samples were stained with calcein AM (viable stain, green) and ethidium 
homodimer (non-viable stain, red) and assessed under a fluorescent microscope (Figure 2). It is 
evident that the cells which are attached to the microcarriers in phase contrast images are indeed 
viable cells given the extent of viability staining exhibited in Figures 2B and 2D. Similar findings 
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were found with the Plastic P102-L and Cytodex-1 pairing and the results depicted in Figure 2 are 
representative of that combination of microcarriers too.   
  
To further demonstrate the bead-to-bead transfer qualitatively, the cells were fluorescently labelled 
with two different fluorescent dyes prior to inoculation on the microcarriers. These Cell Tracker™ 
dyes are virtually non-fluorescent until cytosolic esterases found only inside living cells cleave off 
the acetate moiety, releasing a brightly fluorescent product. Moreover, these reagents pass freely 
through cell membranes, but once inside the cell, are transformed into cell-impermeant reaction 
products. Further, the fluorescent probes are inherited by the daughter cells and are not 
transferrable to adjacent cells in a population. As such, the Cell Tracker™ Red-labelled cells were 
cultured initially only onto Plastic microcarriers (solid) and the Cell Tracker™ Green-labelled cells 
cultured initially only onto the Cytodex-1 microcarriers (transparent) for 2 days. After combining the 
two different types of microcarriers, there was evidence that Cell Tracker™ Red-labelled cells have 
migrated from Plastic onto Cytodex-1 microcarriers (white arrows) and vice versa (yellow arrows) 
(Figure 3A-3D). Notably, the migrated cells exhibited a more rounded morphology than these 
adherent cells normally do. During mitosis, adherent cells undergo a cycle of detachment and re-
attachment (Yamakita et al. 1999) so this could be indicating active cell growth on the ‘new’ 
microcarrier that the cell has migrated to or it could be an indication that following detachment from 
another microcarrier during mitosis, the cell had not yet fully adhered at the time of imaging.  
3.2. Quantitative demonstration of bead-to-bead transfer 
To quantitatively demonstrate bead-to-bead transfer, BM-hMSC1 and BM-hMSC2 were grown for 
6 days on Plastic P102-L microcarriers in either FBS-based or SFM culture conditions (Figure 4, 
Culture 1), after which, 10% of the microcarriers (with cells attached) were seeded into a fresh 
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culture vessel with 90% fresh Plastic P102-L microcarriers (Figure 4, Culture 2). Upon inoculation 
of the microcarriers with cells attached, the vessel was immediately agitated at NJS. This was 
repeated for a third time (Figure 4, Culture 3).  
With each consecutive culture, it is noteworthy that the initial lag phase is reduced and with each 
culture, the final cell density obtained by the end is greater than the previous. This is evident from 
both the cell density data across the three cultures (Figure 4) and the population doublings and 
doubling time data (Table 1). For FBS cultures, the final cell density was found to be ~1.6 x 105 ± 
0.15 cells/mL obtained with Culture 1, 2.01 x 105 ± 0.06 cells/mL in Culture 2 and ~2.15 x 105 ± 
0.08 cells/mL obtained in Culture 3 for hBM-MSC1 and a similar trend was found for hBM-MSC2 
(Figure 4). For SFM cultures, the cell yield was higher in all cases, but the same trend of reduced 
lag phase and increasing yield within the same time period (6 days) was noted. Moreover, in all 
cases, viability was > 95%, indicating favourable culture conditions in the vessel for the growth of 
hMSCs throughout the course of each culture. These findings indicate that a 10% concentration of 
near-to-confluent microcarriers was not only sufficient to inoculate a new vessel containing 90% 
fresh microcarriers, but decreased the lag phase of the new culture and increased the overall yield.  
The findings would appear to demonstrate bead-to-bead transfer given the fact that a 10% 
microcarrier concentration (with cells attached) was able to successfully inoculate a culture vessel 
with fresh microcarriers, with the culture eventually reaching a point of near-confluency prior to 
termination of the culture. Similar findings were observed by Ohlson et al. (1994) and Wang and 
Ouyang (1999) for adherent CHO cells who performed similar inoculation studies with near-
confluent and fresh microcarriers. Moreover, Ohlson et al. (1994) also observed an increase in the 
overall cell yield and a reduced lag phase, similar to what was found in this study. In addition to 
investigating a 10% addition of near-confluent microcarriers to a culture containing fresh 
microcarriers, Ohlson et al. (1994) also investigated inoculating a 25% concentration of near-
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confluent microcarriers to a fresh culture and found that this resulted in a further reduced lag phase 
and an even greater cell density than the 10% near-confluent microcarrier addition. Although a 25% 
concentration of near-confluent microcarriers were not investigated in our study, that earlier finding 
indicates that an important process development activity might be to establish the optimal 
concentration of near-confluent microcarriers to inoculate into fresh bioreactor systems. This 
analysis will undoubtedly be a trade-off between the number of bioreactors to be seeded and the 
desired culture growth kinetics (similar to splitting a near-confluent T-flasks into multiple T-flasks). 
In a separate study, Badenes et al. (2017) demonstrated bead-to-bead transfer with hIPSCs, where 
it was found that this technique facilitated an increase in viable cell number and a concomitant 
significant increase in fold expansion within a 15 day culture. 
To further quantitatively demonstrate the phenomenon of bead-to-bead transfer, a fluorescence 
microscopy-based manual cell counting technique was adopted to highlight the difference between 
two inoculation methods. One (the control) used the well-established technique of cells in free 
suspension and the other, used inoculation of an equivalent number of cells attached to 10% of the 
beads. With these two methods, one would expect there to be a distinct difference in how the 
distribution of the hMSC population across the microcarriers changed over the culture period. For 
the control method using cells in suspension, the expectation would be very few cells per 
microcarrier at the start of the culture and with time as the hMSCs proliferated, this cell distribution 
would shift to higher numbers of cells per microcarriers. With the inoculation via the bead-to-bead 
transfer method, the expectation would be that the cell distribution splits into two distinct 
populations at the start of the culture, one population with a lot of cells, being the microcarriers 
added with cells attached, and the other being empty microcarriers. As the hMSCs proliferate and 
bead-to-bead transfer occurs, one would expect these two populations to merge over the course 
of the growth phase, finally producing similar distributions at the end of the cultures.  
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The data presented (Figure 5A) reflects the expected trends, particularly in the case of inoculating 
cells in suspension as is traditionally done (the control) where the number of cells per bead began 
with many beads without cells at day zero with 75% of beads with 1 to 5 cells on day 1. The 
maximum number of cells per bead steadily increased until eventually at day 5, the maximum 
number of beads were those approaching or at confluence with between 5 to 15 cells per bead on 
the remainder.  
With the inoculation via cells on beads followed by bead-to-bead transfer (Figure 5B), few beads 
have many cells (some approaching confluence) and the remainder have none on day 0.  With the 
passage of time up to day 5, fewer and fewer beads are without cells and the number of cells is 
approximately the same on the other beads and steadily increases. At the end (day 5), a very high 
proportion of the beads are approaching or have reached confluence.  
3.3 Comparison of inoculation techniques  
Having established that BM-hMSCs can transfer to freshly added microcarriers and that a 10% 
concentration of near-confluent microcarriers could act as a sufficient inoculum for a fresh culture, 
to further prove the efficacy of the new approach, it was decided to include cells from a third donor 
(BM-hMSC 3) to supplement the two used in the experiments establishing bead-to-bead transfer 
(BM-hMSC 1, BM-hMSC 2). Also a third culture medium (HPL-based) was included.  The results 
inoculating with these three donor cells on Plastic P102-L microcarriers and three different medium 
are summarised in Figure 6 (FBS-based), Figure 7 (SFM) and Figure 8 (HPL-based). The results 
are also compared to our previous approach of free suspension inoculation as control (Rafiq et al. 
(2016); Heathman et al. (2015a)). Though the results differed between the different medium, the 
data were very similar for each donor cell. Thus, the data presented in Figures 6-9 illustrate a typical 
result for any of the cells in that specific medium conditions.   
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There was a significant improvement in performance between the two approaches in all culture 
medium conditions (FBS, HPL and SFM) throughout the course of the culture, resulting in a higher 
cell density at the end of the culture when utilising cells-on-beads inoculation. For the FBS-based 
culture, the cell density was ~ 2.0 x 105 cells/mL compared to ~1.5 x 105 cells/mL respectively 
(Figure 6A) and for SFM, the final cell densities were ~4.6 x 105 cells/mL, compared to ~3.4 x 105 
cells/mL respectively (Figure 7A). A similar trend was found for HPL, where the values were ~3.6 
x 105 and ~3.0 x 105 cells/mL respectively (Figure 8A). This increase in cell yield is associated with 
a reduced lag phase for all cultures using the cells-on-beads inoculation method, enabling the cells 
to reach the higher growth phase of the culture quicker in comparison to the control. This more 
rapid achievement of fast growth is illustrated in Figures 6-8B and Figures 6-8C.  Figures 6-8 B, 
shows that for FBS, SFM and HPL cultures, the cells’ mean specific growth rate was significantly 
higher between days 0-2 with the cells-on-beads inoculation when compared to the controls 
(Figures 6-8C).  After that, the growth rate for each method reached parity between days 2-4. These 
figures also make clear that there was a reduced lag phase with cells-on-beads inoculation. 
  
The specific glucose consumption rate along with the specific lactate and ammonia production rates 
were also calculated for each culture (Figure 9). For FBS-based culture, the specific glucose 
consumption rate during pre-culture for both the inoculation via cells-on-beads and the control 
method was ~19 pmol.cell-1.d-1. Then between days 0-2 post inoculation, these values sharply rose 
to ~38 pmol.cell-1.d-1 for the inoculation via cells-on-beads and was even higher (~45 pmol.cell-1.d-
1) for the control. Between days 2-4, the glucose consumption rates have settled back down to 
similar values of ~20 pmol.cell-1.d-1 for both methods. This increase in specific glucose consumption 
rate during the first 2 days of culture was mirrored by an increase in the specific lactate and 
ammonia production rates during the same time phase. A distinct trend could be seen across each 
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medium type, where in general an increase in specific consumption/production rates over the first 
2 days of culture was significantly reduced when using the inoculation via cells-on-beads instead 
of the control. It must be noted that all rates were significantly reduced when using a serum-free 
medium. 
This trend suggested that using inoculation by cells-on-beads resulted in a reduced impact on the 
metabolic activity of the hMSCs during the early phase of culture that can likely be attributed to the 
production of extracellular components required for attachment when using the control method. 
Although it has not been explored here, this highlights a potential impact of multiple trypsinisation 
steps on the potency or long-term proliferative capability of hMSCs which could be avoided by 
adopting the inoculation via cells on beads followed by bead to bead transfer. 
With respect to characterisation, the BM-hMSCs, both pre-inoculation and post-harvest were 
characterised with respect to cell identity (immunophenotypic expression) and functionality 
(differentiation potential). In all cases (different culture medium conditions and inoculation 
methods), the BM-hMSCs were found to be in accordance with the ISCT criteria (Dominici et al. 
2006). Representative data is shown for the condition wherein the BM-hMSCs were cultured in 
SFM and inoculated using cells-on-beads. However similar findings were found for all other 
conditions (data not shown). The data demonstrates that there was > 95% co-expression of CD105, 
CD90 and CD73 and less than 2% positive for the negative markers CD34 and HLA-DR for the 
harvested BM-hMSCs (Supplementary Figure 1). Moreover, the cells were analysed for the 
retention of their tri-lineage differentiation potential towards the osteogenic, chondrogenic and 
adipogenic pathways. Again, in all cases, the BM-hMSCs were found to retain their differentiation 
potential (Supplementary Figure 1).  
The impact of this study is particularly relevant to the production phase for hMSC manufacture, 
where the need for large numbers of cells within a limited time period may be necessary. This 
AC
CE
P
ED
 M
AN
US
CR
IPT
approach allows for multiple bioreactors to be inoculated and operated in parallel from a small 
percentage of near-confluent microcarriers, which lends itself well to an allogeneic cell therapy. 
This production approach is akin to T-flask based culture, where a near-confluent T-flask is ‘split’ 
into other T-flasks to facilitate the progression of culture. The  new approach offers a significant 
advantage in that the scale of a stirred-tank bioreactor is significantly larger than that of a T-flask 
and therefore so is the yield of cells that can be obtained. Combined with the ability to increase 
surface area during the course of the culture through the addition of fresh microcarriers, this 
approach facilitates significant expansion potential. Unlike a traditional seed train process from 
primary cells, this process could enable cells to be cultured at relatively low population doublings 
in multiple reactors before either being frozen down as a part of a master/working cell bank, or 
indeed, for the final manufacture of cells. 
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4. Conclusions 
Bead-to-bead transfer is widely believed to occur in anchorage-dependent microcarrier cultures. 
Unlike previous studies investigating this phenomenon, this study describes the approach taken to 
demonstrate bead-to-bead transfer, both qualitatively and quantitatively, for three different BM-
hMSC donors and under different culture medium conditions, FBS, HPL and SFM. Qualitative 
demonstration of the phenomenon was achieved by using microcarriers with distinctive visual 
properties and cell-tracking fluorescent reagents where it was demonstrated that freshly added 
microcarriers to an existing culture were soon populated by BM-hMSCs, with examples of cells 
bridging between different microcarriers, and in other instances cells attaching and proliferating on 
the freshly added microcarriers in isolation. Quantitative demonstration of the phenomenon was 
established by the process of taking 10% of near-confluent microcarriers to inoculate a fresh 
microcarrier culture (cells-on-beads inoculation), where it was found that bead-to-bead transfer not 
only occurred, but that this inoculation method, in contrast to the control (where cells were 
inoculated via free suspension), increased cell growth rate and overall cell yield. The increase in 
cell yield was associated with a reduced lag phase for all cultures using the cells-on-beads 
inoculation method, enabling the cells to reach the higher growth phase of the culture quicker in 
comparison to the control. It was also demonstrated that the cell identity and differentiation potential 
was retained in all culture medium conditions and with both inoculation methods. Cells-on-beads 
inoculation is clearly an effective means of process intensification and can have a significant impact 
on reducing overall expansion times and therefore the costs of BM-hMSC and other anchorage-
dependent cell therapies.  
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Tables: 
Table 1: Population doublings and doubling time data for BM-hMSC1 and BM-hMSC2 in FBS and 
SFM across 3 consecutive cultures 
BM-hMSC line Medium condition Culture number Doubling time (h) Population Doublings 
BM-hMSC1 
FBS 
1 56.4 2.55 
2 51.0 2.82 
3 48.1 2.99 
SFM 
1 40.7 3.54 
2 38.2 3.77 
3 37.0 3.89 
BM-hMSC2 
FBS 
1 58.6 2.46 
2 52.8 2.73 
3 51.4 2.80 
SFM 
1 42.6 3.38 
2 41.6 3.46 
3 40.3 3.57 
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Figure captions 
Figure 1: Phase contrast images of the bead-to-bead transfer between the different types of 
microcarriers, Plastic P102-L (white with black rim), Hillex (red) and Cytodex-1 (translucent white). 
The white arrows indicate cell-microcarrier aggregates between two different microcarriers. The 
black arrows indicate single cells attached to a specific microcarrier. Representative images from 
BM-hMSC1 (A, B, E, F), BM-hMSC2 (C, D, G, H) are illustrated. Figures were taken at day 6 after 
inoculation (3 days after adding the second type of microcarrier).  
Figure 2: Phase contrast (A; C) and Live/Dead staining (B; D) images of the same microcarriers 
and cells demonstrating the bead-to-bead transfer. Representative images from BM-hMSC1 (A,B) 
and BM-hMSC2 (C,D) are depicted with similar findings across both donors used. Figures were 
taken at day 6 after inoculation (3 days after adding the second type of microcarrier). The 
microcarriers used were Plastic (white with black rim) and Hillex (red). 
Figure 3: Fluorescent and bright field images showing Cell Tracker Red-labelled cells migrated 
from Plastic (solid) to Cytodex-1 (transparent) microcarriers (white arrows) and Cell Tracker Green-
labelled cells migrated from Cytodex-1 to Plastic microcarriers (yellow arrows). (A) Bright field 
image; (B) Cell Tracker-Green; (C) Cell Tracker-Red; (D) Merged. Scale bar represents 100 µm.  
Figure 4: Quantitative demonstration of bead-to-bead culture in FBS and SFM cultures with BM-
hMSC1 and BM-hMSC2 donor cells cultured on Plastic P102-L microcarriers. Data show mean ± 
SD, n = 3. 
Figure 5: Cell distribution on microcarriers when using (A) the standard cell inoculation method or 
(B) the cells-on-beads inoculation method. The gradiation in colour (from light to dark) represents 
the numbers of cells on microcarriers. Data represents BM-hMSC3 cells cultured on Plastic P102-
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L microcarriers in HPL. The data is representative of findings from the other donor cells and cultured 
in the other medium compositions. 
Figure 6: Comparison of BM-hMSC1 growth on Plastic P102-L microcarriers in a FBS-containing 
medium when using the standard cell inoculation (control) or cells-on-beads inoculation, where the 
data represents, (A) the cell density (cells/mL) over 7 days, (B) the mean specific growth rate (d-1) 
over the course of the culture and (C) a logarithmic plot of the cell density across the culture period. 
Data show mean ± SD, n = 3. Significance was determined at p < 0.05 (*) or at p < 0.01 (**).  
Figure 7: Comparison of BM-hMSC2 growth on Plastic P102-L microcarriers in the SFM when using 
the standard cell inoculation (control) or cells-on-beads inoculation, where the data represents, (A) 
the cell density (cells/mL) over 7 days, (B) the mean specific growth rate (d-1) over the course of 
the culture and (C) a logarithmic plot of the cell density across the culture period. Data show mean 
± SD, n = 3. Significance was determined at p < 0.05 (*) or at p < 0.01 (**). 
Figure 8: Comparison of BM-hMSC3 growth on Plastic P102-L microcarriers in a HPL-containing 
medium when using the standard cell inoculation (control) or cells-on-beads inoculation, where the 
data represents, (A) the cell density (cells/mL) over 7 days, (B) the mean specific growth rate (d-1) 
over the course of the culture and (C) a logarithmic plot of the cell density across the culture period. 
Data show mean ± SD, n = 3. Significance was determined at p < 0.05 (*) or at p < 0.01 (**). 
Figure 9: Metabolite data for the cultures comparing the standard cell inoculation (control) and cells-
on-beads inoculation across the different culture medium conditions, FBS, HPL and SFM. (A-C) 
represents the mean specific glucose consumption rate (pmol.cell-1.d-1), the mean specific lactate 
production rate (pmol.cell-1.d-1) and the mean specific ammonia production rate (pmol.cell-1.d-1) for 
the FBS culture. (D-F) represents the mean specific glucose consumption rate (pmol.cell-1.d-1), the 
mean specific lactate production rate (pmol.cell-1.d-1) and the mean specific ammonia production 
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rate (pmol.cell-1.mL-1) for the HPL culture. (G-I) represents the mean specific glucose consumption 
rate (pmol.cell-1.mL-1), the mean specific lactate production rate (pmol.cell-1.d-1) and the mean 
specific ammonia production rate (pmol.cell-1.d-1) for the SFM culture. Data show mean ± SD, n = 
3. 
Supplementary Figure 1: Immunophenotypic expression for BM-hMSC1 (A) and differentiation of 
the BM-hMSC1 toward the (B) adipogenic, (C) osteogenic and (D) chondrogenic lineages. All data 
are of cells cultured on Plastic P102-L microcarriers. Representative data was obtained for all other 
cell donors and in all other medium conditions. 
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